Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Ahead of print

Issues

Results of the second external quality assessment for human papillomavirus genotyping in Shanghai, China

Xueliang Wang
  • Corresponding author
  • Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, 528 Hongshan Road, Pudong, Shanghai 200126, P.R. China, Phone: +86 21 68316300, Fax: +86 21 68318311
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Haiming Wang
  • Department of Clinical Laboratory, Gongli Hospital, Second Military Medical University, Shanghai, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yixiao Yang
  • Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lingli Jiang
  • Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yun Bao
  • Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yanqun Xiao
  • Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Hualiang Wang
  • Corresponding author
  • Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, 528 Hongshan Road, Pudong, Shanghai 200126, P.R. China, Phone: +86 21 68316300, Fax: +86 21 68318311
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-07-08 | DOI: https://doi.org/10.1515/cclm-2019-0127

References

  • 1.

    Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.PubMedCrossrefGoogle Scholar

  • 2.

    Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol 2015;136:178–82.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 3.

    Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol 2010;11:1160–71.Web of ScienceCrossrefPubMedGoogle Scholar

  • 4.

    Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 2015;21:817–26.Web of SciencePubMedCrossrefGoogle Scholar

  • 5.

    Wang X, Liu F, Jiang L, Bao Y, Xiao Y, Wang H. External quality assessment for human papillomavirus 16/18 DNA detection and genotyping in Shanghai, China. Clin Chem Lab Med 2017;55:195–202.Web of ScienceGoogle Scholar

  • 6.

    Zhang R, Huang J, Wang P, Sun Y, Zhang K, Xie J, et al. Proficiency test for human papillomavirus genotyping in china. Intervirology 2013;56:295–301.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 7.

    Rao A, Young S, Erlich H, Boyle S, Krevolin M, Sun R, et al. Development and characterization of the cobas human papillomavirus test. J Clin Microbiol 2013;51:1478–84.Web of SciencePubMedCrossrefGoogle Scholar

  • 8.

    Arbyn M, Tommasino M, Depuydt C, Dillner J. Are 20 human papillomavirus types causing cervical cancer? J Pathol 2014;234:431–5.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 9.

    Cuzick J, Wheeler C. Need for expanded HPV genotyping for cervical screening. Papillomavirus Res 2016;2:112–5.Web of ScienceCrossrefPubMedGoogle Scholar

  • 10.

    Robadi IA, Pharaon M, Ducatman BS. The importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia. Arch Pathol Lab Med 2018;142:693–5.Web of ScienceCrossrefPubMedGoogle Scholar

About the article

Received: 2018-12-03

Accepted: 2019-05-22

Published Online: 2019-07-08


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: This study was funded by the Three-year Action Program of Shanghai Municipality for Strengthening the Construction of the Public Health System (2015–2017) (No. 15GWZK0301) and Shanghai Municipal Commission of Health and Family Planning (No. 201740002).

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), 20190127, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2019-0127.

Export Citation

© 2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in